Japan · Delayed Price · Currency is JPY Kohjin Bio Statistics
Total Valuation
Kohjin Bio has a market cap or net worth of JPY 5.19 billion. The enterprise value is 4.90 billion.
| Market Cap | 5.19B |
| Enterprise Value | 4.90B |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Kohjin Bio has 5.11 million shares outstanding. The number of shares has increased by 1.34% in one year.
| Current Share Class | 5.11M |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | +1.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 55.34% |
| Owned by Institutions (%) | 16.90% |
| Float | 1.54M |
Valuation Ratios
The trailing PE ratio is 20.69.
| PE Ratio | 20.69 |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.35, with an EV/FCF ratio of -18.01.
| EV / Earnings | 19.51 |
| EV / Sales | 0.99 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 13.06 |
| EV / FCF | -18.01 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.80 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 2.97 |
| Debt / FCF | -8.05 |
| Interest Coverage | 9.00 |
Financial Efficiency
Return on equity (ROE) is 4.28% and return on invested capital (ROIC) is 4.61%.
| Return on Equity (ROE) | 4.28% |
| Return on Assets (ROA) | 2.38% |
| Return on Invested Capital (ROIC) | 4.61% |
| Return on Capital Employed (ROCE) | 5.23% |
| Weighted Average Cost of Capital (WACC) | 3.69% |
| Revenue Per Employee | 29.57M |
| Profits Per Employee | 1.50M |
| Employee Count | 167 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, Kohjin Bio has paid 81.00 million in taxes.
| Income Tax | 81.00M |
| Effective Tax Rate | 24.40% |
Stock Price Statistics
The stock price has decreased by -37.86% in the last 52 weeks. The beta is 0.08, so Kohjin Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -37.86% |
| 50-Day Moving Average | 1,281.88 |
| 200-Day Moving Average | 1,434.60 |
| Relative Strength Index (RSI) | 37.04 |
| Average Volume (20 Days) | 36,730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kohjin Bio had revenue of JPY 4.94 billion and earned 251.00 million in profits. Earnings per share was 49.10.
| Revenue | 4.94B |
| Gross Profit | 1.86B |
| Operating Income | 342.00M |
| Pretax Income | 332.00M |
| Net Income | 251.00M |
| EBITDA | 738.00M |
| EBIT | 342.00M |
| Earnings Per Share (EPS) | 49.10 |
Balance Sheet
The company has 2.49 billion in cash and 2.19 billion in debt, with a net cash position of 296.00 million or 57.91 per share.
| Cash & Cash Equivalents | 2.49B |
| Total Debt | 2.19B |
| Net Cash | 296.00M |
| Net Cash Per Share | 57.91 |
| Equity (Book Value) | 5.94B |
| Book Value Per Share | 1,162.85 |
| Working Capital | 1.90B |
Cash Flow
In the last 12 months, operating cash flow was 698.00 million and capital expenditures -970.00 million, giving a free cash flow of -272.00 million.
| Operating Cash Flow | 698.00M |
| Capital Expenditures | -970.00M |
| Depreciation & Amortization | 396.00M |
| Net Borrowing | -150.00M |
| Free Cash Flow | -272.00M |
| FCF Per Share | -53.21 |
Margins
Gross margin is 37.60%, with operating and profit margins of 6.92% and 5.08%.
| Gross Margin | 37.60% |
| Operating Margin | 6.92% |
| Pretax Margin | 6.72% |
| Profit Margin | 5.08% |
| EBITDA Margin | 14.94% |
| EBIT Margin | 6.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 2.50%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 2.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.61% |
| Buyback Yield | -1.34% |
| Shareholder Yield | 1.07% |
| Earnings Yield | 4.83% |
| FCF Yield | -5.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kohjin Bio has an Altman Z-Score of 3.07 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.07 |
| Piotroski F-Score | 5 |